demonstrated through experiments that SLFN11 targets RPS4X via the MTR signaling pathway, suggesting its significance in suppressing hepatocellular carcinoma (HCC) initiation and metastasis (49). This evidence concerns the gene SLFN11 and hepatocellular carcinoma.